HIV and Drugs: Public health - the missing link
UNAIDS discussion brief. Key facts and a public health approach to drug control
Harm reduction for people who inject drugs in New York has worked, but hasn’t reduced racial inequality
Needle and syringe exchange and opiate substitution therapy in New York City has worked in reducing HIV infection in people who inject drugs (PWIDs) to the extent of almost abolishing HIV infection in white people who inject drugs, but HIV prevalence in black people who inject drugs remains high.
Bereaved through substance use
Guidelines for those whose work brings them into contact with adults bereaved after a drug or alcohol-related death.
UNODC annual report 2014
Contents include: Drugs, health and trafficking, Transnational organised crime, Justice, Corruption, Terrorism, Policy support and public affairs, Research, trend analysis and forensics, Independent evaluation, and Finances and funding.
Recommendations for UNGASS 2016 Outcome Document on Controlled Medicines
Ensuring the availability of controlled substances for medical and scientific purposes while preventing their misuse and diversion is a fundamental objective of the UN drug conventions and an obligation for Member States.
Recommandations de l'UNGASS 2016 - Document final sur les médicaments contrôlés
Recommendations for UNGASS 2016 Outcome Document on Controlled Medicines: French language version.
Recomendaciones para el Documento Final sobre Medicamentos Controlados del UNGASS 2016
Recommendations for UNGASS 2016 Outcome Document on Controlled Medicines: Spanish language version.
DrugFacts: Is Marijuana Medicine?
The term medical marijuana refers to using the whole unprocessed marijuana plant or its basic extracts to treat a disease or symptom. The U.S. Food and Drug Administration (FDA) has not recognized or approved the marijuana plant as medicine.
Opus divinum
This month’s story by Dr Jasna Cuk Rupnik MD from Center for prevention and treatment of addiction of illicit drugs, Logatec, Slovenia.
Cannabis: how spending five minutes in primary care can make a difference
SMMGP - At a time of changing regulation and an increasing acceptance and evidence base for its use as a medicine across diverse conditions, GPs could be left thinking that it’s all a bit confusing and wondering what their stance should be in clinical practice.
Share this on: